Not provided
Not provided
Not provided
Not provided
Not provided
Lack of funding
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Assessing the use of corneal confocal microscopy to evaluate for early neuropathy changes in subjects with Type 1 Diabetes.
Rationale: Poorly controlled diabetes mellitus is associated with microvascular complications, which includes peripheral neuropathy. Peripheral neuropathy associated with diabetes is a painful condition. Its diagnosis is hampered by painful and long nerve conduction studies which fail to diagnose small nerve neuropathy. It is important to study methods of noninvasive methods of early detection, which are sensitive and specific in diagnosing early neuropathy and we propose a novel study that this can be detected in the cornea of the eye.
Aims:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Type 1 Diabetes | Active Comparator | Subjects with known Type 1 diabetes |
|
| Healthy Controls | Placebo Comparator | Healthy controls |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Corneal confocal microscopy | Device | Confocal miscroscopy will be used to assess corneal nerve changes due to hyperglycemia. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Corneal small nerve fiber damage | Estimate corneal small nerve fiber damage in young T1DM subjects and compare the results to healthy controls using corneal confocal microscopy (CCM). This will be done by examining the cornea via confocal microscopy and obtaining images. These images will be evaluated looking at how many nerves there are, how they branch, and how long they are). | Assessed one time per subject during study (study completed over 3 years) |
| Normative values for corneal confocal microscopy (CCM) | Obtain much needed normative values for CCM in adolescents and intraepidermal nerve fiber density from skin biopsies in subjects with type 1 diabetes. This will be done by obtaining a small biopsy of skin and looking at the number of nerve fibers in the outer layer of the skin. | Assessed one time per subject during study (study completed over 3 years) |
| Measure | Description | Time Frame |
|---|---|---|
| Serum biomarkers - leptin | Measuring serum biomarkers (blood levels) leptin. In participants with diabetes, comparing the blood level measurements of those with neuropathy vs. those without neuropathy. | Assessed one time per subject during study (study completed over 3 years) |
| Serum biomarkers - TNF Alpha |
Not provided
Inclusion:
Matched Controls:
Exclusion:
For all subjects:
For healthy controls
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Lisa Underland, MD | Montefiore Medical Center at Albert Einstein College of Medicine | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D003929 | Diabetic Neuropathies |
| ID | Term |
|---|---|
| D010523 | Peripheral Nervous System Diseases |
| D009468 | Neuromuscular Diseases |
| D009422 | Nervous System Diseases |
| D048909 | Diabetes Complications |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Skin biopsy | Procedure | Skin biopsy will be used to assess the appearance of nerve fibers in subjects with type 1 diabetes. |
|
| Nerve conduction study | Procedure | Nerve conduction studies will be use to assess for neuropathy. |
|
| Blood draw | Other | Subjects will undergo a one time blood draw for biomarkers. |
|
Measuring serum biomarkers (blood levels) Tumor Necrosis Factor (TNF) Alpha. In participants with diabetes, comparing the blood level measurements of those with neuropathy vs. those without neuropathy. |
| Assessed one time per subject during study (study completed over 3 years) |
| Serum biomarkers - fibrinogen | Measuring serum biomarkers (blood levels) fibrinogen. In participants with diabetes, comparing the blood level measurements of those with neuropathy vs. those without neuropathy. | Assessed one time per subject during study (study completed over 3 years) |
| D003920 | Diabetes Mellitus |
| D004700 | Endocrine System Diseases |
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |